146 related articles for article (PubMed ID: 32609899)
1. Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients.
Chaichotjinda K; Anurathapan U; Boonsathorn S; Chaisavaneeyakorn S; Treepongkaruna S; Techasaensiri C; Apiwattanakul N
Clin Transplant; 2020 Oct; 34(10):e14024. PubMed ID: 32609899
[TBL] [Abstract][Full Text] [Related]
2. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation.
Idilman R; Ustün C; Karayalçin S; Aktemel A; Turkyilmaz AR; Ozcan M; Arslan O; Bozdayi AM; Van Thiel DH; Akan H
Clin Transplant; 2003 Oct; 17(5):438-43. PubMed ID: 14703927
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.
Ceneli O; Ozkurt ZN; Acar K; Rota S; Aki SZ; Yeğin ZA; Yağci M; Ozenirler S; Sucak GT
World J Gastroenterol; 2010 Apr; 16(14):1765-71. PubMed ID: 20380010
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
[TBL] [Abstract][Full Text] [Related]
6. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.
Murt A; Elverdi T; Eskazan AE; Salihoglu A; Ar MC; Ongoren S; Baslar Z; Soysal T
Ann Hematol; 2020 Nov; 99(11):2671-2677. PubMed ID: 32737632
[TBL] [Abstract][Full Text] [Related]
11. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.
Beulens C; Raven SFH; van Jaarsveld CHM; van Loo I; Boland G; Visser LG; Hoebe CJPA; Vossen ACTM
Vaccine; 2022 May; 40(23):3210-3215. PubMed ID: 35469696
[TBL] [Abstract][Full Text] [Related]
13. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Conrad A; Perry M; Langlois ME; Labussière-Wallet H; Barraco F; Ducastelle-Leprêtre S; Larcher MV; Balsat M; Boccard M; Chidiac C; Ferry T; Roure-Sobas C; Salles G; Valour F; Ader F;
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1729-1737. PubMed ID: 32428736
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies persistence after revaccination with three doses of hepatitis B vaccine in non-responsive adults: results from 8-year follow-up study].
Yan BY; Lyu JJ; Feng Y; Cao CZ; Meng X; Liang XF; Wang FZ; Xu AQ; Zhang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1546-1552. PubMed ID: 34814582
[No Abstract] [Full Text] [Related]
16. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
Nishikawa K; Kimura K; Kanda Y; Sugiyama M; Kakihana K; Doki N; Ohashi K; Bae SK; Takahashi K; Ishihara Y; Mizuno I; Onishi Y; Onozawa M; Onizuka M; Yamamoto M; Ishikawa T; Inoue K; Kusumoto S; Hashino S; Saito H; Kanto T; Sakamaki H; Mizokami M
Bone Marrow Transplant; 2020 Jul; 55(7):1388-1398. PubMed ID: 32071416
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U; Sethakarun S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
19. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
20. Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation-Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers.
Piekarska A; Wisniewski P; Lewandowski K; Gil L; Trzonkowski P; Bieniaszewska M; Zaucha JM
Front Immunol; 2020; 11():586523. PubMed ID: 33335530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
